Omega Therapeutics Future Growth
Future criteria checks 2/6
Omega Therapeutics is forecast to grow earnings and revenue by 13.1% and 60.2% per annum respectively while EPS is expected to grow by 24.3% per annum.
Key information
13.1%
Earnings growth rate
24.3%
EPS growth rate
Biotechs earnings growth | 24.6% |
Revenue growth rate | 60.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 May 2024 |
Recent future growth updates
Recent updates
Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'
Mar 31Is Omega Therapeutics (NASDAQ:OMGA) Weighed On By Its Debt Load?
Feb 28Omega Therapeutics: The Next Weight Loss Drug Runner
Jan 16Omega Therapeutics: Starting 2024 With A Bang
Jan 10Omega Therapeutics GAAP EPS of -$0.54 in-line, revenue of $0.48M beats by $0.43M
Aug 04Omega Therapeutics gets FDA nod to start liver cancer trial of lead drug OTX-2002
Jul 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 27 | -139 | -114 | N/A | 3 |
12/31/2025 | 1 | -93 | -82 | N/A | 7 |
12/31/2024 | 4 | -78 | -92 | N/A | 6 |
3/31/2024 | 5 | -92 | -79 | -75 | N/A |
12/31/2023 | 3 | -97 | -94 | -92 | N/A |
9/30/2023 | 3 | -108 | -101 | -99 | N/A |
6/30/2023 | 3 | -112 | -102 | -100 | N/A |
3/31/2023 | 2 | -108 | -105 | -103 | N/A |
12/31/2022 | 2 | -103 | -100 | -99 | N/A |
9/30/2022 | 1 | -93 | -92 | -90 | N/A |
6/30/2022 | 1 | -85 | -83 | -82 | N/A |
3/31/2022 | 0 | -75 | -72 | -70 | N/A |
12/31/2021 | 0 | -68 | -59 | -58 | N/A |
9/30/2021 | N/A | -57 | -52 | -50 | N/A |
6/30/2021 | N/A | -47 | -43 | -40 | N/A |
3/31/2021 | N/A | -38 | -33 | -31 | N/A |
12/31/2020 | N/A | -29 | -28 | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMGA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OMGA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OMGA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OMGA's revenue (60.2% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: OMGA's revenue (60.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OMGA's Return on Equity is forecast to be high in 3 years time